☆ 4.4 Letter

Combination treatment with metronomic temozolomide, bevacizumab and long-acting octreotide for malignant neuroendocrine tumours

ENDOCRINE-RELATED CANCER (2012)

Journal

ENDOCRINE-RELATED CANCER

Volume 19, Issue 1, Pages L1-L4

Publisher

BIOSCIENTIFICA LTD

DOI: 10.1530/ERC-11-0287

Keywords

-

Categories

Oncology Endocrinology & Metabolism

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.